Vistagen Therap
VTGN----
Q4 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Vistagen Therap(VTGN) predict that the Revenue is 465 K (--%), Beat estimate;the EBIT is -16.72 M (-15.33%), Miss estimate;the EPS is -0.37 (+15.91%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B--
0.00B--
+0.00B--%
EBITMiss expectations
-0.02B15.33%
-0.01B3.81%
-0.00B19.14%
EPSMiss expectations
-0.3715.91%
-0.3227.27%
-0.050011.36%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf